Researching: GLP-1
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "GLP-1"...
RxInsider Coverage (10)
The Week
The Oral GLP-1 Tracker: Lilly's Foundayo launch remains 'muted'
Jul 11
The Week
Can pharma sustain its $2T trajectory?
Jul 2
The Week
What is pulmonary hypertension and why would a new GLP-1 help?
Jun 26
The Week
Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
Jun 21
The Week
Regulatory tracker: Novo's oral GLP-1 picks up UK approval
Jun 14
The Week
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
Jun 9
The Week
With a promising MASH asset, muscle-sparing GLP-1 and new CEO, Rivus gets ready to make its mark
Jun 9
The Week
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
Jun 9
The Week
Opinion: I'm a weight-loss doctor. Here's why I worry about GLP-1 'microdoses'
May 29
Pipeline
CHMP Diverges from FDA, Backs AZ’s Camizestrant and Novo’s Oral Wegovy
May 23
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.